Literature DB >> 24838313

Caspase-activated DNase is necessary and sufficient for oligonucleosomal DNA breakdown, but not for chromatin disassembly during caspase-dependent apoptosis of LN-18 glioblastoma cells.

María Sánchez-Osuna1, Mercè Garcia-Belinchón1, Victoria Iglesias-Guimarais1, Estel Gil-Guiñón1, Elisenda Casanelles1, Victor J Yuste2.   

Abstract

Caspase-dependent apoptosis is a controlled type of cell death characterized by oligonucleosomal DNA breakdown and major nuclear morphological alterations. Other kinds of cell death do not share these highly distinctive traits because caspase-activated DNase (DFF40/CAD) remains inactive. Here, we report that human glioblastoma multiforme-derived LN-18 cells do not hydrolyze DNA into oligonucleosomal fragments after apoptotic insult. Furthermore, their chromatin remains packaged into a single mass, with no signs of nuclear fragmentation. However, ultrastructural analysis reveals that nuclear disassembly occurs, although compacted chromatin does not localize into apoptotic nuclear bodies. Caspases become properly activated, and ICAD, the inhibitor of DFF40/CAD, is correctly processed. Using cell-free in vitro assays, we show that chromatin from isolated nuclei of LN-18 cells is suitable for hydrolysis into oligonuclesomal fragments by staurosporine-pretreated SH-SY5Y cytoplasms. However, staurosporine-pretreated LN-18 cytoplasms do not induce DNA laddering in isolated nuclei from either LN-18 or SH-SY5Y cells because LN-18 cells express lower amounts of DFF40/CAD. DFF40/CAD overexpression makes LN-18 cells fully competent to degrade their DNA into oligonucleosome-sized fragments, and yet they remain unable to arrange their chromatin into nuclear clumps after apoptotic insult. Indeed, isolated nuclei from LN-18 cells were resistant to undergoing apoptotic nuclear morphology in vitro. The use of LN-18 cells has uncovered a previously unsuspected cellular model, whereby a caspase-dependent chromatin package is DFF40/CAD-independent, and DFF40/CAD-mediated double-strand DNA fragmentation does not warrant the distribution of the chromatin into apoptotic nuclear bodies. The studies highlight a not-yet reported DFF40/CAD-independent mechanism driving conformational nuclear changes during caspase-dependent cell death.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Apoptosis; Apoptotic Nuclear Morphology; Caspase; Chromatin Disassembly; DFF40/CAD; DNA; Deoxyribonuclease (DNase); Nucleus; Oligonucleosomal DNA Fragmentation

Mesh:

Substances:

Year:  2014        PMID: 24838313      PMCID: PMC4081919          DOI: 10.1074/jbc.M114.550020

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

1.  Modeling apoptotic chromatin condensation in normal cell nuclei. Requirement for intranuclear mobility and actin involvement.

Authors:  Piotr Widlak; Olena Palyvoda; Slawomir Kumala; William T Garrard
Journal:  J Biol Chem       Date:  2002-04-01       Impact factor: 5.157

2.  Chromatin structure and endonuclease sensitivity in human leukemic cell lines.

Authors:  N Kuribayashi; H Sakagami; M Iida; M Takeda
Journal:  Anticancer Res       Date:  1996 May-Jun       Impact factor: 2.480

3.  A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity.

Authors:  T Decker; M L Lohmann-Matthes
Journal:  J Immunol Methods       Date:  1988-11-25       Impact factor: 2.303

4.  Multiple pathways for apoptotic nuclear fragmentation.

Authors:  L Dini; S Coppola; M T Ruzittu; L Ghibelli
Journal:  Exp Cell Res       Date:  1996-03-15       Impact factor: 3.905

Review 5.  Mechanisms and genes of cellular suicide.

Authors:  H Steller
Journal:  Science       Date:  1995-03-10       Impact factor: 47.728

6.  Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis.

Authors:  A H Wyllie; R G Morris; A L Smith; D Dunlop
Journal:  J Pathol       Date:  1984-01       Impact factor: 7.996

Review 7.  The DFF40/CAD endonuclease and its role in apoptosis.

Authors:  P Widłak
Journal:  Acta Biochim Pol       Date:  2000       Impact factor: 2.149

8.  The CED-3/ICE-like protease Mch2 is activated during apoptosis and cleaves the death substrate lamin A.

Authors:  K Orth; A M Chinnaiyan; M Garg; C J Froelich; V M Dixit
Journal:  J Biol Chem       Date:  1996-07-12       Impact factor: 5.157

Review 9.  Why target apoptosis in cancer treatment?

Authors:  Shailaja Kasibhatla; Ben Tseng
Journal:  Mol Cancer Ther       Date:  2003-06       Impact factor: 6.261

10.  Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation.

Authors:  F Oberhammer; J W Wilson; C Dive; I D Morris; J A Hickman; A E Wakeling; P R Walker; M Sikorska
Journal:  EMBO J       Date:  1993-09       Impact factor: 11.598

View more
  3 in total

1.  An intrinsic DFF40/CAD endonuclease deficiency impairs oligonucleosomal DNA hydrolysis during caspase-dependent cell death: a common trait in human glioblastoma cells.

Authors:  María Sánchez-Osuna; Laura Martínez-Escardó; Carla Granados-Colomina; Fina Martínez-Soler; Sònia Pascual-Guiral; Victoria Iglesias-Guimarais; Roser Velasco; Gerard Plans; Noemi Vidal; Avelina Tortosa; Carlos Barcia; Jordi Bruna; Victor J Yuste
Journal:  Neuro Oncol       Date:  2016-01-10       Impact factor: 12.300

2.  An Early and Robust Activation of Caspases Heads Cells for a Regulated Form of Necrotic-like Cell Death.

Authors:  Mercè Garcia-Belinchón; María Sánchez-Osuna; Laura Martínez-Escardó; Carla Granados-Colomina; Sònia Pascual-Guiral; Victoria Iglesias-Guimarais; Elisenda Casanelles; Judit Ribas; Victor J Yuste
Journal:  J Biol Chem       Date:  2015-06-29       Impact factor: 5.157

Review 3.  The role of the DFF40/CAD endonuclease in genomic stability.

Authors:  Merve Kulbay; Nathan Bernier-Parker; Jacques Bernier
Journal:  Apoptosis       Date:  2021-01-02       Impact factor: 4.677

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.